Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00850421 · ClinicalTrials.gov registry record · NA
Pilot Study of BOTOX for Migraine Headaches
A NA study, sponsored by HealthPartners Institute.
- Terminated
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT00850421 is a NA study that was terminated before completion, run by HealthPartners Institute. The registered enrollment target is 35 participants.
The verdict
NCT00850421, a NA study, was terminated before completion, sponsored by HealthPartners Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
The purposes of this study are to assess whether subjects treated with BOTOX will: 1. have a decrease in the frequency and intensity of migraine headaches 2. experience improvements in quality of life 3. experience a reduction in the frequency of health care services obtained.
Interventions
- DRUG Botulinum Toxin Type A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2004-04 |
| Est. Completion | 2010-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00850421
The ClinicalTrials.gov registry entry for NCT00850421 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HealthPartners Institute, which has 146 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Botulinum Toxin Type A is the first listed.
NCT00850421 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00850421 about?
NCT00850421 is a clinical study titled "Pilot Study of BOTOX for Migraine Headaches". The purposes of this study are to assess whether subjects treated with BOTOX will: 1. have a decrease in the frequency and intensity of migraine headaches 2. experience improvements in quality of life 3. experience a reduction in the frequency of health care services obtained.
What is the current status of trial NCT00850421?
This trial is currently terminated. It is a NA study. The enrollment target is 35 participants. The study started on 2004-04. Estimated completion is 2010-04.
What interventions are being tested in trial NCT00850421?
The interventions under investigation include: Botulinum Toxin Type A (DRUG).
Who is sponsoring clinical trial NCT00850421?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.